tiprankstipranks
Trending News
More News >
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market

Spyre Therapeutics (SYRE) Technical Analysis

Compare
450 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
2Neutral
8Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
6Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Spyre Therapeutics’s (SYRE) Moving Averages Convergence Divergence (MACD) indicator is 0.74, suggesting Spyre Therapeutics is a Sell.
Spyre Therapeutics’s (SYRE) 20-Day exponential moving average is 15.92, while Spyre Therapeutics’s (SYRE) share price is $18.56, making it a Buy.
Spyre Therapeutics’s (SYRE) 50-Day exponential moving average is 15.84, while Spyre Therapeutics’s (SYRE) share price is $18.56, making it a Buy.

Spyre Therapeutics (SYRE) Pivot Points

Jun 11, 2025, 10:41 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
16.18
16.51
16.83
17.16
17.48
17.81
18.13
Fibonacci
16.51
16.75
16.91
17.16
17.40
17.56
17.81
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Spyre Therapeutics (SYRE) Moving Averages

Jun 11, 2025, 10:41 PM
Period
Simple
Exponential
MA5
17.17Buy
17.31Buy
MA10
16.37Buy
16.63Buy
MA20
15.66Buy
15.92Buy
MA50
14.52Buy
15.84Buy
MA100
17.51Buy
17.68Buy
MA200
23.00Sell
21.68Sell
Spyre Therapeutics’s (SYRE) 10-Day exponential moving average is 16.63, while Spyre Therapeutics’s (SYRE) share price is $18.56, making it a Buy.
Spyre Therapeutics’s (SYRE) 100-Day exponential moving average is 17.68, while Spyre Therapeutics’s (SYRE) share price is $18.56, making it a Buy.
Spyre Therapeutics’s (SYRE) stock price is $18.56 and Spyre Therapeutics’s (SYRE) 50-day simple moving average is 14.52, creating a Buy signal.
Spyre Therapeutics’s (SYRE) stock price is $18.56 and Spyre Therapeutics’s (SYRE) 100-day simple moving average is 17.51, creating a Buy signal.
Spyre Therapeutics’s (SYRE) stock price is $18.56 and Spyre Therapeutics’s (SYRE) 200-day simple moving average is 23.00, creating a Sell signal.

Spyre Therapeutics (SYRE) Technical Indicators

Jun 11, 2025, 10:41 PM
Name
Value
Implied Action
RSI (14)
73.81
Sell
STOCH (9,6)
85.94
Sell
STOCHRSI (14)
86.67
Sell
MACD (12,26)
0.74
Sell
ADX (14)
23.98
Neutral
Williams %R
-6.37
Sell
CCI (14)
211.62
Sell
ATR (14)
0.97
-
Ultimate Oscillator
61.47
Neutral
ROC
20.52
Buy
Spyre Therapeutics’s (SYRE) Relative Strength Index (RSI) is 73.81, creating a Sell signal.
Spyre Therapeutics’s (SYRE) Trend Strength Indicator (ADX) is 23.98, creating a Neutral signal.
Spyre Therapeutics’s (SYRE) Commodity Channel Index (CCI) is 211.62, creating a Sell signal.
Spyre Therapeutics’s (SYRE) Price Rate of Change (ROC) is 20.52, creating a Buy signal.

FAQ

Is SYRE a Buy, Hold, or Sell?
Based on SYRE’s technical indicators, SYRE is a Buy.
    What is SYRE’s RSI (14)?
    SYRE’s RSI (14) is 73.81, which suggests SYRE is a Sell.
      What is SYRE’s MACD?
      SYRE’s MACD is 0.74, which suggests SYRE is a Sell.
        What is SYRE’s 5-day moving average?
        SYRE’s 5-day moving average is 17.17, which suggests SYRE is a Buy.
          What is SYRE’s 20-day moving average?
          SYRE 20-day moving average is 15.66, which suggests SYRE is a Buy.
            What is SYRE’s 50-day moving average?
            SYRE’s 50-day moving average is 14.52, which suggests SYRE is a Buy.
              What is SYRE’s 200-day moving average?
              SYRE’s 200-day moving average is 23.00, which suggests SYRE is a Sell.
                What is SYRE’s Williams % R (14)?
                SYRE’s Williams % R (14) is -6.37, which suggests SYRE is a Sell.
                  What is SYRE’s CCI (14)?
                  SYRE’s CCI (14) is 211.62, which suggests SYRE is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis